– USA, CA – CooperCompanies (Nasdaq: COO), a leading global medical device company, announced the appointment of Barbara Carbone to its Board as an independent director, effective May 1, 2025, bringing nearly four decades of experience across a wide variety of industries.
Barbara Carbone has also joined the Audit Committee.
About Barbara Carbone
Barbara Carbone spent most of her career at KPMG LLP, from 1981-2019, where she served more than twenty-four years as an Audit Partner. She served on the KPMG Partnership Audit Committee for six years, including three years as the Chairperson, and as the National Partner in Charge for Human Resources, involved in designing performance management processes, compensation strategies, and training & development programs. She also served on the KPMG Retired Partners Council from 2019-2022.
Barbara Carbone serves as the Chairperson on the Board of Directors of TrueCar, Inc., and as a member of the Board of Directors of Limoneira Company and Bob’s Discount Furniture. Ms. Carbone holds a B.S. in Business Administration (Accountancy) from California State University at Sacramento.
About CooperCompanies
CooperCompanies is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see every day. CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies has a workforce of more than 16,000, sells products in over 130 countries, and positively impacts over fifty million lives each year.
For more: https://www.coopercos.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.